Elutia Inc.
ELUT- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001708527
No open-market purchases or sales by Elutia Inc. insiders were filed in the last 90 days; 39 institutions reported holding it in 13F filings for Q2 2026, worth $13.8M in total; no superinvestor holds it.
13F holders, Q1 2022
Institutional positions in Elutia Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 17
- +2 vs. Q4 2021
- Shares held
- 3.29M
- +50.7K (+1.6%) vs. Q4 2021
- Total value
- $19.4M
- −$411.0K (−2.1%) vs. Q4 2021
- New holders
- 2
- 1 more added
- Sold out
- 0
- 7 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ELUT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 39 | $13.8M |
| Q1 2026 | 35 | $16.0M |
| Q4 2025 | 33 | $11.1M |
| Q3 2025 | 31 | $16.1M |
| Q2 2025 | 28 | $34.4M |
| Q1 2025 | 31 | $43.6M |
| Q4 2024 | 32 | $49.3M |
| Q3 2024 | 29 | $46.7M |
| Q2 2024 | 26 | $44.5M |
| Q1 2024 | 22 | $17.9M |
| Q4 2023 | 24 | $14.9M |
| Q3 2023 | 21 | $9.20M |
| Q2 2023 | 19 | $7.23M |
| Q1 2023 | 18 | $4.20M |
| Q4 2022 | 19 | $18.4M |
| Q3 2022 | 17 | $24.0M |
| Q2 2022 | 17 | $23.6M |
| Q1 2022 | 17 | $19.4M |
| Q4 2021 | 15 | $19.8M |
| Q3 2021 | 17 | $13.2M |
| Q2 2021 | 24 | $19.7M |
| Q1 2021 | 31 | $23.5M |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Elutia Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Birchview Capital, LP | 1,417,923 | $8.28M | 5.96% | 00.0% | Unchanged |
| Endurant Capital Management LP | 1,109,479 | $6.60M | 1.99% | +33,839+3.1% | Added |
| Brown Advisory Inc | 230,667 | $1.37M | 0.00% | 00.0% | Unchanged |
| Perkins Capital Management Inc | 227,729 | $1.35M | 1.11% | 00.0% | Unchanged |
| Platinum Investment Management Ltd | 188,181 | $1.12M | 0.03% | −7,628−3.9% | Reduced |
| Vanguard Group Inc | 55,570 | $331.0K | 0.00% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 24,900 | $148.0K | 0.00% | +24,900 | New |
| Millennium Management LLC | 14,543 | $87.0K | 0.00% | −2,519−14.8% | Reduced |
| BlackRock Inc. | 6,383 | $38.0K | 0.00% | −315−4.7% | Reduced |
| Barclays PLC | 3,029 | $18.0K | 0.00% | +3,029 | New |
| Morgan Stanley | 2,880 | $17.0K | 0.00% | −288−9.1% | Reduced |
| UBS Group AG | 1,558 | $9.00K | 0.00% | −13−0.8% | Reduced |
| Tower Research Capital LLC (TRC) | 1,204 | $7.00K | 0.00% | −231−16.1% | Reduced |
| US Bancorp | 625 | $4.00K | 0.00% | 00.0% | Unchanged |
| Nisa Investment Advisors, LLC | 547 | $3.00K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 12 | $0 | 0.00% | −51−81.0% | Reduced |
| Wells Fargo & Company | 27 | $0 | 0.00% | 00.0% | Unchanged |